Skip to main content

Table 2 Prevalence of CHB and coverage of expanded program on HBV immunization in international traveler’s to Asia departure countries outside Asia [12–14]

From: Hepatitis B vaccination for international travelers to Asia

Region

Country

International traveler’s departures per year (2013)

Estimated prevalence of chronic hepatitis B infectiona

Estimated HBsAg positive population

Start of Expanded Program of Immunization (EPI) for HBV (Year)

Complete HBV vaccination (%)

Number of years since EPI deployed, at year 2016

N. America

USA

61,569,000

0.27 %

843,724

1993

90

23

 

Canada

32,977,000

0.76 %

260,865

2003

75

13

S. America

Mexico

15,911,000

0.20 %

237,858

2000

84

16

 

Argentina

7,544,000

0.77 %

312,806

2002

94

14

Europe

United Kingdom

58,510,000

0.01 %

3,300

Not started

N/A

N/A

 

Russia

54,069,000

2.73 %

3,926,499

2001

97

15

 

Italy

27,798,000

2.52 %

1,522,546

1991

94

25

 

France

26,243,000

0.26 %

165,728

1998

82

18

 

Ukraine

23,761,000

1.45 %

666,280

2000

46

16

 

Netherlands

18,094,000

0.40 %

67,009

2013

95

2

 

Hungary

15,997,000

0.53 %

53,301

Not started

N/A

N/A

 

Sweden

15,917,000

0.59 %

55,606

2011

42

5

 

Spain

11,246,000

0.34 %

158,287

1996

96

20

Oceania

Australia

8,768,000

0.37 %

83,121

2001

91

15

 

New Zealand

2,193,000

4.11 %

179,357

1992

93

24

Africa

South Africa

5,168,000

6.70 %

3,445,477

1997

74

19

 

Uganda

378,000

9.19 %

3,123,886

2002

78

14

  1. a Estimated at year 2015 based on data on prevalence of chronic HBV infection published between Jan 1, 1965, and Oct 23, 2013